[1]
“Tolvaptan to Achieving High Urine Output and Avoiding Hyponatremia in COVID-19 with ADHF Patient: Case Report”, World Journal of Current Med and Pharm Research, vol. 3, no. 5, pp. 123–126, Oct. 2021, doi: 10.37022/wjcmpr.v3i5.195.